MindBio Therapeutics Corp. (CSE: MBIO)

MindBio Therapeutics Statistics

Total Valuation

MindBio Therapeutics has a market cap or net worth of CAD 2.70 million. The enterprise value is 7.20 million.

Market Cap	2.70M
Enterprise Value	7.20M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

MindBio Therapeutics has 135.05 million shares outstanding. The number of shares has increased by 4.59% in one year.

Current Share Class	n/a
Shares Outstanding	135.05M
Shares Change (YoY)	+4.59%
Shares Change (QoQ)	-2.21%
Owned by Insiders (%)	5.76%
Owned by Institutions (%)	n/a
Float	127.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.10
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.70

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-179.00%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.00%
50-Day Moving Average	0.03
200-Day Moving Average	0.04
Relative Strength Index (RSI)	43.36
Average Volume (20 Days)	44,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-515,362
Pretax Income	-255,560
Net Income	-256,357
EBITDA	n/a
EBIT	-515,362
Earnings Per Share (EPS)	-0.00

Balance Sheet

The company has 47,142 in cash and 4.60 million in debt, giving a net cash position of -4.55 million or -0.03 per share.

Cash & Cash Equivalents	47,142
Total Debt	4.60M
Net Cash	-4.55M
Net Cash Per Share	-0.03
Equity (Book Value)	-5.42M
Book Value Per Share	-0.04
Working Capital	-5.13M

Cash Flow

Operating Cash Flow	-86,928
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MindBio Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.59%
Shareholder Yield	-4.59%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a